SCHEMBL5263741

SCHEMBL5263741

NCCC1CCCC(CCNC(=O)OCc2ccccc2)C1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 2/20 0.51
HTT P42858 1/20 0.49
CPB1 P15086 2/20 0.47
IDO1 P14902 1/20 0.47
TDO2 P48775 1/20 0.47
TSHR P16473 1/20 0.47
GAA P10253 1/20 0.46
TPSAB1 Q15661 1/20 0.45
TPSD1 Q9BZJ3 1/20 0.45
TPSG1 Q9NRR2 1/20 0.45
SLC1A3 P43003 1/20 0.45
SLC1A1 P43005 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5263738 1.00 MEN1 (0.55) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL8396013 0.89 LMNA (0.60) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL8391394 0.86 MEN1 (0.63) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL8393973 0.85 MEN1 (0.65) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL8393628 0.85 MEN1 (0.65) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL5914164 0.83 MEN1 (0.53) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL5263736 0.83 MEN1 (0.53) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL8396587 0.83 LMNA (0.63) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL8392818 0.81 HTT (0.62) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL3940775 0.80 LMNA (0.56) MEN1KMT2ALMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO disclosed